RedHill Biopharma Ltd. (RDHL) Form 6-K — Jul 1, 2026
RedHill Biopharma Ltd. has rescheduled its annual general meeting of shareholders from July 28, 2026, to August 6, 2026, in order to furnish updated proxy materials that include an additional proposal for shareholder consideration. The record date for determining shareholders entitled to vote at the meeting is July 2, 2026. The meeting agenda includes four proposals: the re-appointment of Kesselman & Kesselman as auditors, the re-election of directors Rick D.
Key figures
- Shares Outstanding
- 60,809,201,000
- Record date
- July 2, 2026
- Meeting date
- August 6, 2026
- Ads outstanding
- 6,080,920
- Authorized capital nis
- 5,000,000,000
- Authorized shares ordinary
- 499,994,000,000
- Authorized shares preferred
- 6,000,000
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.